CN101862336B - 一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 - Google Patents
一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 Download PDFInfo
- Publication number
- CN101862336B CN101862336B CN2010102112910A CN201010211291A CN101862336B CN 101862336 B CN101862336 B CN 101862336B CN 2010102112910 A CN2010102112910 A CN 2010102112910A CN 201010211291 A CN201010211291 A CN 201010211291A CN 101862336 B CN101862336 B CN 101862336B
- Authority
- CN
- China
- Prior art keywords
- irbesartan
- hydrochlorothiazide
- liposome
- preparation
- solid preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102112910A CN101862336B (zh) | 2010-06-29 | 2010-06-29 | 一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102112910A CN101862336B (zh) | 2010-06-29 | 2010-06-29 | 一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101862336A CN101862336A (zh) | 2010-10-20 |
CN101862336B true CN101862336B (zh) | 2011-09-14 |
Family
ID=42954396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102112910A Expired - Fee Related CN101862336B (zh) | 2010-06-29 | 2010-06-29 | 一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101862336B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579345B (zh) * | 2012-03-02 | 2013-09-25 | 海南美兰史克制药有限公司 | 厄贝沙坦脂质体固体制剂 |
CN103040841B (zh) * | 2013-01-09 | 2014-04-30 | 南京正大天晴制药有限公司 | 一种含厄贝沙坦和氢氯噻嗪的药物组合物 |
WO2016013031A1 (en) * | 2014-07-25 | 2016-01-28 | Sun Pharma Advanced Research Company Ltd. | Liposome composition and method of preparing the liposome |
CN113171352A (zh) * | 2021-04-15 | 2021-07-27 | 海南锦瑞制药有限公司 | 一种沙坦类降压复方制剂的制备方法 |
-
2010
- 2010-06-29 CN CN2010102112910A patent/CN101862336B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101862336A (zh) | 2010-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101797230B (zh) | 一种氯沙坦钾氢氯噻嗪药物组合物脂质体固体制剂 | |
HUE030674T2 (en) | A pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or a salt thereof | |
CN102579350A (zh) | 右旋布洛芬脂质体固体制剂 | |
KR20090114320A (ko) | 심혈관계 질환 치료용 약제학적 제제 | |
CN101862336B (zh) | 一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 | |
CN105338970A (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
CN102258492A (zh) | 溴新斯的明缓释片剂及其制备方法 | |
CN109875972B (zh) | 一种奥美沙坦酯氨氯地平药物组合物 | |
CN101972263B (zh) | 一种缬沙坦氢氯噻嗪药物组合物脂质体固体制剂 | |
CN102166208B (zh) | 赖诺普利氢氯噻嗪药物组合物脂质体固体制剂 | |
CN100525760C (zh) | 盐酸度洛西汀缓释药物 | |
CN101816640A (zh) | 普拉格雷脂质体固体制剂 | |
RU2414903C1 (ru) | Фармацевтический состав пролонгированного действия на основе клозапина перорального введения | |
CN115192572B (zh) | 布立西坦药剂、其制备方法和应用 | |
CN101862329B (zh) | 一种氨氯地平阿托伐他汀钙药物组合物脂质体固体制剂 | |
CN102614188A (zh) | 含有缬沙坦、左旋氨氯地平和氢氯噻嗪的胶囊剂及其制法 | |
CA2893480C (en) | Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide | |
CN102138899B (zh) | 阿齐沙坦酯脂质体固体制剂 | |
CN110575443A (zh) | 一种多索茶碱缓释片及其制备方法 | |
CN103142518B (zh) | 一种阿格列汀脂质体固体制剂及其制备方法和应用 | |
CN102626395B (zh) | 一种阿利克仑缬沙坦药物组合物脂质体固体制剂 | |
CN101829071B (zh) | 一种阿利克仑脂质体片剂 | |
RU2506947C2 (ru) | Таблетка пролонгированного высвобождения, содержащая теобромин | |
CN102579345B (zh) | 厄贝沙坦脂质体固体制剂 | |
CN102626391B (zh) | 一种阿利克仑氢氯噻嗪药物组合物脂质体固体制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN MEILAN SHIKE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TAO LINGGANG Effective date: 20130723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130723 Address after: 6, No. 570216, Haikou Free Trade Zone, 168 Nanhai Avenue, Hainan, Haikou Patentee after: Hainan Meilan Shike Pharmaceutical Co., Ltd. Address before: The new business building No. 48 570125 Hainan city of Haikou province China World Trade Center Road, room 2601 Patentee before: Tao Linggang |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20160629 |